http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#head http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#provenance http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://rdf.disgenet.org/resource/gda/DGN01fc45e0af26bef01d7269efb4aa2869 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1956 http://rdf.disgenet.org/resource/gda/DGN01fc45e0af26bef01d7269efb4aa2869 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0007131 http://rdf.disgenet.org/resource/gda/DGN01fc45e0af26bef01d7269efb4aa2869 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#provenance http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://purl.org/dc/terms/description [The objective of this study was to compare the incremental cost-effectiveness ratios of strategies for second-line erlotinib initiation in NSCLC: clinically guided initiation (nonsmoking females with adenocarcinoma received erlotinib; all other patients received docetaxel) and biologically guided selection (patients with epidermal growth factor receptor (EGFR) mutation received erlotinib; patients with wild-type EGFR or unknown status received docetaxel), compared with initiation with no patient selection (strategy reference).A Markov model was constructed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/21659409 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/dc/terms/created 2017-10-17T13:12:13+02:00 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP321388.RAJSmoCMmTggc7ZRbDY870H1sJmGYqMOldFv6IS5NDPJo http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0